Newer, more intense chemotherapy with less radiation not more effective against Hodgkin's lymphoma, study finds

A lower dose of radiation used to reduce side effects is not as effective as the regular dose when given with the standard chemotherapy in the treatment of Hodgkin's lymphoma patients with early, intermediate-stage disease, according to a first-of-its-kind randomized study.

Read the whole article on Science Daily

More from Science Daily